Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis. - Wikidata - awgldk - TriplyDB

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.

http://www.wikidata.org/entity/Q33214445

about

Primary biliary cirrhosis: From bench to bedside Activation of anti-hepatitis C virus responses via Toll-like receptor 7.Toll-like receptors in pathophysiology of liver diseases Concept on the pathogenesis and treatment of primary biliary cirrhosis Biliary innate immunity: function and modulation.Toll-like receptor 3 in liver diseases.Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis Toll-like receptors in liver fibrosis: cellular crosstalk and mechanisms Genes and (auto)immunity in primary biliary cirrhosis.Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system.The role of vitamin d in primary biliary cirrhosis: possible genetic and cell signaling mechanisms Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?Inflammatory regulation by TLR3 in acute hepatitis Increased expression of Toll-like receptor 3 in intrahepatic biliary epithelial cells at sites of ductular reaction in diseased livers Toll-like receptors as targets in chronic liver diseases.Role of gut microbiota in liver diseases.Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.Toll-like receptors as therapeutic targets in gastrointestinal diseases.Immunological orchestration of liver fibrosis.Toll-like receptors and liver disease.Cholangiopathy with respect to biliary innate immunity.Characterization of the innate immune signalling pathways in hepatocyte cell lines.IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules.Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjögren's syndrome.Protective Effects of S-Adenosylmethionine and Its Combinations With Taurine and/or Betaine Against Lipopolysaccharide or Polyinosinic-polycytidylic Acid-induced Acute Hepatotoxicity.Influence of genes, sex, age and environment on the onset of autoimmune hepatitis.The multi-hit hypothesis of primary biliary cirrhosis: polyinosinic-polycytidylic acid (poly I:C) and murine autoimmune cholangitis.Toll-like receptor 3 polymorphism and its association with hepatitis B virus infection in Saudi Arabian patients.Systemic and local expression levels of TNF-like ligand 1A and its decoy receptor 3 are increased in primary biliary cirrhosis.Sclerosing and obstructive cholangiopathy in biliary atresia: mechanisms and association with biliary innate immunity.Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis.Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.Guidelines for the management of primary biliary cirrhosis

P2860

Q26799419-394E8EAB-A829-4031-B9D6-E2B43C3B5373 Q27473105-0DF00B24-C6A9-4C77-A1E3-E59750CFD36B Q28070077-88DFD547-81D0-42B6-9E94-92A49DD919C7 Q33866454-3436C96C-994A-4E18-A22B-B70EC8222341 Q34080138-B5FC6E3D-6CC6-4D83-B2F4-BB9A49642BEF Q34170010-34DB5904-781A-4B8F-AF1A-BE6493531F1D Q34802178-4C033B57-CC29-498A-AB78-F499B3EE9920 Q35977675-F23C3E2A-86E5-461E-9A7A-B085D109F2E1 Q36202209-1C44A106-D233-48DF-B45D-B11723F9D5B6 Q36577483-C9154D94-B093-403B-A6A4-34F966E249BD Q36754953-F5444141-B240-4318-BFDF-F2A977AA9901 Q37198685-754EC457-B8B7-4E81-AE7E-DA2763FF80FF Q37209443-62EB24A8-F65C-4BC7-8003-C44F2B926659 Q37278147-CC1909C1-90B0-460E-85A7-088D4AD0BD73 Q37469924-7F889917-46F7-428D-9946-940482E9F8FD Q37488165-9717396B-BF69-41D7-A158-FCBEE1673828 Q37588732-D5CC9E95-B1AE-428D-A002-CD17B09B3442 Q37690323-68F0E8D7-CB61-414E-8135-9C4A1C78C9EC Q38018539-B55925E1-B345-4DE6-8B2D-0D0EBF5DE685 Q38151944-DCA3B211-E157-464E-8C9A-1176FE3DE38D Q38346143-C2D51DBC-0377-4832-8739-FD445BE0FAC6 Q39955016-F2A22243-E5E9-4476-B345-0B4927A1EF99 Q40133679-5830AE74-7954-42ED-A4D2-2BEB1571C3EA Q40170759-9947055C-CB6A-403D-B05C-6B7B000DCB08 Q40512227-4A6B76EA-6DDB-429F-9521-BAF82273CEA1 Q43163687-60C36924-3344-4ABF-9859-A9413AF0449C Q43785645-CC5AA7BA-5A6F-486E-BB09-36063E2B5AD4 Q45356002-68314B2C-88B8-4402-BAB5-9992C6A98836 Q46193410-5BB9AAEC-CA4D-4773-BDA0-DC28DF050975 Q47610257-87414453-1BC9-40AD-8BE7-5EB030C30456 Q51560561-E95554A9-DFA5-4E19-88A3-68386CFD167A Q53136572-FC37A2B8-19E2-4147-8EB3-31709FFFA364 Q54606882-08C7F14B-18F6-4964-8768-1C5457AA8718 Q56429943-D2B52A7B-C097-4FB6-A883-29C7F99F330D

P2860

Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis.

http://www.wikidata.org/entity/Q33214445

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Enhanced expression of type I ...... in primary biliary cirrhosis.

@ast

Enhanced expression of type I ...... in primary biliary cirrhosis.

@en

type

label

Enhanced expression of type I ...... in primary biliary cirrhosis.

@ast

Enhanced expression of type I ...... in primary biliary cirrhosis.

@en

prefLabel

Enhanced expression of type I ...... in primary biliary cirrhosis.

@ast

Enhanced expression of type I ...... in primary biliary cirrhosis.

@en

P1433

Q33214445-FBF46ED1-CB79-4144-9462-F259537B7304

P1476

Q33214445-3B3CF0C1-2DDB-451C-AF39-0C5910F24529

P2093

Q33214445-06E3830C-EE55-41ED-A05C-7887CBAE0D5D

Q33214445-1824FFEB-C68C-4D87-9004-BCE26EA10F9C

Q33214445-1E384859-4D6B-46FA-B703-8A77A6DF8A26

Q33214445-1F0859D8-C54B-4144-9D97-8739CDB3D077

Q33214445-2901FD33-7FA4-4245-8BE5-FB42F9D4254B

Q33214445-2BA2AA44-6C0E-478C-AE9A-A80340FC5F9C

Q33214445-2E9B1D78-3EE3-4F1B-BB57-089F791F1135

Q33214445-4D830E00-20F3-44AD-AC22-F28FC59B9DD2

Q33214445-50D2AEFA-721E-423C-9DA7-EE9D12E83E15

Q33214445-650A8401-64BE-4A2F-A2C2-E152ADF37B4C

P2860

Q33214445-06CF4695-F6F0-4C24-900A-45E9C73EFECA

Q33214445-10FD7501-1ED8-4CDD-94CB-86D43F30404C

Q33214445-18079E77-7C2A-4B40-A03E-2B7AB6A35638

Q33214445-18FA094E-7837-4EF9-9574-8A6C60897B81

Q33214445-22482E52-3B85-4677-BE3C-B25E1E839E9A

Q33214445-288A467F-A820-42B4-B66F-D7DC4F88D733

Q33214445-2C809448-9D7D-431F-A9F2-055CD1470DD1

Q33214445-2D6E48C1-BA22-4E96-B026-04F4757EE2D3

Q33214445-3B211680-579E-4623-9F45-FE298CF2D8DA

Q33214445-40291D69-A221-4C6B-B0EF-F9F52533E4E4

P2888

Q33214445-B6146DE4-DFF7-4FFA-8AB1-75B94E5F69B9

P304

Q33214445-0499F22D-AB13-4BCE-8CCC-E70738F556F0

P31

Q33214445-0EC3B13D-EC8E-4D8A-B9D3-73ABEF76765A

P356

Q33214445-F99EB8A6-6280-41CB-B264-3557CF227832

P433

Q33214445-F5355344-E7EF-4AE1-A7AD-A1EB91BADCDF

P478

Q33214445-351E62FE-7B12-4B28-9D23-78EDB3315D35

P577

Q33214445-FFB843EC-98F8-40BD-A2BE-BF618D080595

P5875

Q33214445-F8F7DA3B-6B0B-49C4-92F7-DA76B4DEC801

P6179

Q33214445-D3104ADA-A1C4-4309-A995-64BC8D1A5725

P698

Q33214445-40A9BAE7-55E2-4B7A-83AC-3ECA79016973

P921

Q33214445-DEEF4459-FFE9-41BE-B73C-6B7E8A5B5787

P356

LABINVEST.3700285

P1433

Laboratory Investigation

P1476

Enhanced expression of type I ...... in primary biliary cirrhosis.

@en

P2093

Atsumasa Komori

http://www.w3.org/2001/XMLSchema#string

Hikaru Fujioka

http://www.w3.org/2001/XMLSchema#string

Hiromi Ishibashi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Yatsuhashi

http://www.w3.org/2001/XMLSchema#string

Ken Taniguchi

http://www.w3.org/2001/XMLSchema#string

Kiyoshi Migita

http://www.w3.org/2001/XMLSchema#string

Koichiro Kusumoto

http://www.w3.org/2001/XMLSchema#string

Koji Yano

http://www.w3.org/2001/XMLSchema#string

Manabu Daikoku

http://www.w3.org/2001/XMLSchema#string

Masahiro Ito

http://www.w3.org/2001/XMLSchema#string

P2860

Functional role of type I and type II interferons in antiviral defense

IFNs activate toll-like receptor gene expression in viral infections

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

Toll-like receptor signalling

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4

Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity

IRF family of transcription factors as regulators of host defense

Cloning the human betaretrovirus proviral genome from patients with primary biliary cirrhosis.

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

P2888

labinvest.3700285

P304

908-920

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LABINVEST.3700285

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7882101

http://www.w3.org/2001/XMLSchema#string

P6179

1034603806

http://www.w3.org/2001/XMLSchema#string

P698

15856047

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor